Pep-1, as a specific ligand of interleukin 13 receptor α2 (IL-13Rα2) with high specificity and affinity, can interact with IL-13Rα2, thereby passing the blood–tumor barrier (BTB) and homing in on the glioma [296]. This evidence concerns the gene IL13RA2 and central nervous system cancer.